Atlas Trials

Expanded Access for Bulevirtide

Clinical trial NCT06780579 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT06780579
Sponsor
Gilead Sciences
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Chronic Hepatitis Delta Virus Infection

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.